EUVIMEDEUVIMED entdecken
Crossref

Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation

Liang Zhao, Yizhen Pang, Daqiang Xu, Jianhao Chen, Shan Yu, Dan Ruan, Lingyu Yu, Zhenyu Wu, Guoqiang Su, Hua Wu, Lin Ai, Long Sun und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-02 · 53 (3) · 1479-1490

DOI: 10.1007/s00259-025-07512-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 23.08.2025. Verfasst von Liang Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen Universi…. Hauptthemen laut MEDLINE: Membrane Proteins, Positron-Emission Tomography, Gelatinases, Serine Endopeptidases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare, Key Scientific Research Program for Yong Scholars in Fujian, Fujian Natural Science Foundation for Distinguished Yong Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Accurate delineation of tumor margins and maximal safe resection are critical for successful curative oncologic surgery. However, fibroblast activation protein (FAP)-targeted probes suitable for fluorescence imaging remain limited. Here, we developed novel FAP-targeted fluorescent probes to accurately delineate tumor margins and enable rapid intraoperative identification of tumor boundaries in resected specimens. METHODS: DOTA chelator for radiolabelling with gallium-68 was incorporated into dual-modality FAP-targeted probes synthesised by conjugating FAP-2286 and 3BP-3940 with the near-infrared (NIR) fluorophore IRDye800CW. These probes were evaluated both in vitro and in vivo using HEK293T-FAP cells stably expressing FAP and xenograft mouse models. Positron emission tomography (PET) and (NIR-II) fluorescence imaging assessed the specificity and ability of probes to delineate tumor margins. For clinical validation, resected lung tissue was incubated ex vivo with the probes. Tumor regions and margins were identified using fluorescence imaging and subsequently validated by haematoxylin and eosin (H&E) staining and FAP immunohistochemistry. RESULTS: Both IRDye800CW-FAP-2286 and IRDye800CW-3BP-3940 exhibited high affinity for FAP-positive cells in vitro. PET imaging revealed high tumor specificity for both probes in vivo. In vivo and ex vivo NIR-II fluorescence imaging enabled accurate visualisation of tumor margins, with IRDye800CW-3BP-3940 exhibiting superior performance compared with IRDye800CW-FAP-2286. In the clinical specimen, IRDye800CW-3BP-3940 successfully delineated tumor regions with strong concordance to histopathological findings. CONCLUSION: We developed and validated a novel dual-modality molecular probe, IRDye800CW-3BP-3940, which integrated PET and NIR fluorescence imaging capabilities. This probe enabled highly specific detection of FAP-positive tumors and precise delineation of tumor margins in resected specimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsPositron-Emission TomographyGelatinasesSerine EndopeptidasesFluorescent DyesOptical ImagingMargins of ExcisionHumansAnimalsMicePilot ProjectsEndopeptidasesHEK293 CellsFemaleMultimodal ImagingMaleGallium RadioisotopesCell Line, Tumor

Stichwörter der Autor:innen

Dual-ModalityFAPNear-infrared imagingPET

Substanzen

Membrane ProteinsGelatinasesSerine EndopeptidasesFluorescent DyesEndopeptidasesGallium Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361003, China.
  • Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Colorectal Tumor Surgery, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
  • Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361003, China. 1317…

ORCID-Profile: Haojun Chen

Förderung

  • National Natural Science Foundation of China
  • Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare, Key Scientific Research Program for Yong Scholars in Fujian
  • Fujian Natural Science Foundation for Distinguished Yong Scholars

Zitieren

APA

Zhao, L., Pang, Y., Xu, D., Chen, J., Yu, S., Ruan, D., Yu, L., Wu, Z., Su, G., Wu, H., Ai, L., Sun, L., Fan, D., & Chen, H. (2026). Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation. European Journal of Nuclear Medicine and Molecular Imaging, 53(3), 1479-1490. https://doi.org/10.1007/s00259-025-07512-8

Vancouver

Zhao L, Pang Y, Xu D, Chen J, Yu S, Ruan D, et al. Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(3):1479-1490. doi:10.1007/s00259-025-07512-8

BibTeX
@article{Zhao2026,
  author = {Zhao, Liang and Pang, Yizhen and Xu, Daqiang and Chen, Jianhao and Yu, Shan and Ruan, Dan and Yu, Lingyu and Wu, Zhenyu and Su, Guoqiang and Wu, Hua and Ai, Lin and Sun, Long and Fan, Di and Chen, Haojun},
  title = {Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {3},
  pages = {1479--1490},
  doi = {10.1007/s00259-025-07512-8}
}
Kostenlos starten →